Search

everythinglearnresearchcommunity

for

Search:↓

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Certain gene variations may increase the risk and severity of alopecia areata.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Finasteride safely lowers DHT levels without affecting testosterone.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

A specific gene change in APCDD1 increases the risk of hair loss.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Finasteride effectively treats hair loss and prostate issues by blocking a specific enzyme.

5α-reductase inhibitors are effective for treating hair loss in androgenetic alopecia.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

Men with Addison disease should be screened for X-linked adrenoleukodystrophy if they have hair loss.

The document's conclusion cannot be provided because the document is not available or cannot be read.